Redmile Group as of Sept. 30, 2018
Portfolio Holdings for Redmile Group
Redmile Group holds 83 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 7.4 | $242M | 16M | 15.20 | |
| Atara Biotherapeutics | 5.4 | $174M | 4.2M | 41.35 | |
| Fate Therapeutics (FATE) | 5.2 | $169M | 10M | 16.29 | |
| Regenxbio Inc equity us cm (RGNX) | 3.9 | $125M | 1.7M | 75.50 | |
| Xencor (XNCR) | 3.6 | $118M | 3.0M | 38.97 | |
| ImmunoGen | 3.6 | $117M | 12M | 9.47 | |
| Wave Life Sciences (WVE) | 3.5 | $114M | 2.3M | 50.00 | |
| Alder Biopharmaceuticals | 3.3 | $108M | 6.5M | 16.65 | |
| Amicus Therapeutics (FOLD) | 3.1 | $102M | 8.4M | 12.09 | |
| Audentes Therapeutics | 2.7 | $89M | 2.2M | 39.59 | |
| CIGNA Corporation | 2.4 | $77M | 370k | 208.25 | |
| Livanova Plc Ord (LIVN) | 2.3 | $74M | 599k | 123.97 | |
| Argenx Se (ARGX) | 2.3 | $74M | 975k | 75.84 | |
| Inflarx Nv (IFRX) | 2.1 | $70M | 2.0M | 34.32 | |
| Allakos | 2.0 | $66M | 1.5M | 44.99 | |
| Anthem (ELV) | 2.0 | $64M | 234k | 274.05 | |
| Wright Medical Group Nv | 1.9 | $63M | 2.2M | 29.02 | |
| Anaptysbio Inc Common (ANAB) | 1.9 | $63M | 630k | 99.77 | |
| Uniqure Nv (QURE) | 1.8 | $60M | 1.6M | 36.39 | |
| Deciphera Pharmaceuticals | 1.8 | $57M | 1.5M | 38.72 | |
| Clovis Oncology | 1.6 | $52M | 1.8M | 29.37 | |
| ICU Medical, Incorporated (ICUI) | 1.6 | $52M | 182k | 282.75 | |
| WellCare Health Plans | 1.5 | $50M | 156k | 320.49 | |
| Tandem Diabetes Care (TNDM) | 1.4 | $46M | 1.1M | 42.84 | |
| Scholar Rock Hldg Corp (SRRK) | 1.4 | $46M | 1.8M | 25.75 | |
| Nightstar Therapeutics | 1.3 | $43M | 2.1M | 20.43 | |
| Xeris Pharmaceuticals | 1.3 | $42M | 2.4M | 17.58 | |
| eHealth (EHTH) | 1.3 | $42M | 1.5M | 28.26 | |
| Heska Corporation | 1.3 | $41M | 362k | 113.31 | |
| UnitedHealth (UNH) | 1.2 | $39M | 146k | 266.04 | |
| Bluebird Bio | 1.1 | $37M | 252k | 146.00 | |
| Oxford Immunotec Global | 1.1 | $36M | 2.2M | 16.23 | |
| Replimune Group (REPL) | 1.1 | $35M | 2.2M | 16.10 | |
| Cymabay Therapeutics | 1.0 | $33M | 3.0M | 11.08 | |
| Penumbra (PEN) | 1.0 | $33M | 217k | 149.70 | |
| Centene Corporation (CNC) | 1.0 | $32M | 222k | 144.78 | |
| Gritstone Oncology Ord (GRTSQ) | 1.0 | $32M | 2.2M | 14.24 | |
| NuVasive | 1.0 | $31M | 440k | 70.98 | |
| CVS Caremark Corporation (CVS) | 0.9 | $31M | 394k | 78.72 | |
| Catalent | 0.9 | $31M | 669k | 45.55 | |
| Glycomimetics | 0.9 | $30M | 2.0M | 14.40 | |
| Teladoc (TDOC) | 0.9 | $29M | 335k | 86.35 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.9 | $28M | 1.5M | 19.35 | |
| Alder Biopharmaceuticals Inc convertible security | 0.8 | $27M | 25M | 1.08 | |
| Morphosys (MOR) | 0.7 | $24M | 900k | 26.70 | |
| Epizyme | 0.7 | $24M | 2.2M | 10.60 | |
| Array Biopharma Inc bond | 0.7 | $24M | 19M | 1.25 | |
| Zoetis Inc Cl A (ZTS) | 0.7 | $23M | 253k | 91.56 | |
| LHC | 0.7 | $22M | 218k | 102.99 | |
| Pra Health Sciences | 0.7 | $22M | 200k | 110.19 | |
| Syneos Health | 0.7 | $22M | 429k | 51.55 | |
| Agilent Technologies Inc C ommon (A) | 0.7 | $22M | 306k | 70.54 | |
| Syros Pharmaceuticals | 0.6 | $20M | 1.7M | 11.91 | |
| Elanco Animal Health (ELAN) | 0.6 | $18M | 525k | 34.89 | |
| Tricida | 0.5 | $15M | 495k | 30.55 | |
| Chimerix (CMRX) | 0.4 | $14M | 3.6M | 3.89 | |
| Odonate Therapeutics Ord | 0.4 | $12M | 605k | 19.41 | |
| Surgery Partners (SGRY) | 0.3 | $11M | 634k | 16.50 | |
| Invitae (NVTAQ) | 0.3 | $8.8M | 525k | 16.73 | |
| Eidos Therapeutics | 0.3 | $8.7M | 868k | 9.98 | |
| IntriCon Corporation | 0.2 | $7.0M | 125k | 56.20 | |
| Beigene (ONC) | 0.2 | $6.9M | 40k | 172.21 | |
| Neuronetics (STIM) | 0.2 | $5.8M | 181k | 32.06 | |
| Ovid Therapeutics (OVID) | 0.1 | $4.1M | 730k | 5.67 | |
| Establishment Labs Holdings Ord (ESTA) | 0.1 | $3.6M | 150k | 24.10 | |
| Jounce Therapeutics | 0.1 | $2.8M | 425k | 6.50 | |
| Arvinas Ord (ARVN) | 0.1 | $2.3M | 136k | 16.87 | |
| Endologix | 0.1 | $1.5M | 811k | 1.91 | |
| Ra Med Sys | 0.1 | $1.5M | 85k | 18.20 | |
| Repligen Corporation (RGEN) | 0.0 | $1.1M | 20k | 55.45 | |
| Viking Therapeutics (VKTX) | 0.0 | $523k | 30k | 17.43 | |
| Amedisys (AMED) | 0.0 | $341k | 2.7k | 125.14 | |
| iShares Dow Jones US Health Care (IHF) | 0.0 | $417k | 2.1k | 199.81 | |
| Jazz Pharmaceuticals (JAZZ) | 0.0 | $267k | 1.6k | 167.92 | |
| Heron Therapeutics (HRTX) | 0.0 | $343k | 11k | 31.61 | |
| Flexion Therapeutics | 0.0 | $248k | 13k | 18.70 | |
| Sage Therapeutics (SAGE) | 0.0 | $307k | 2.2k | 141.47 | |
| Vericel (VCEL) | 0.0 | $283k | 20k | 14.15 | |
| Aclaris Therapeutics (ACRS) | 0.0 | $164k | 11k | 14.49 | |
| Myokardia | 0.0 | $467k | 7.2k | 65.13 | |
| Senseonics Hldgs (SENS) | 0.0 | $214k | 45k | 4.77 | |
| Castlight Health | 0.0 | $28k | 10k | 2.74 | |
| Adverum Biotechnologies | 0.0 | $135k | 22k | 6.07 |
